Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Down 6% – What’s Next?

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) dropped 6% during mid-day trading on Friday. The stock traded as low as $12.67 and last traded at $12.6850. 7,950 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 1,110,588 shares. The stock had previously closed at $13.50.

Wall Street Analyst Weigh In

BAYRY has been the subject of a number of research analyst reports. Zacks Research raised shares of Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 10th. Deutsche Bank Aktiengesellschaft upgraded Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a research report on Thursday, July 2nd. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy”.

Bayer Aktiengesellschaft Price Performance

The company has a quick ratio of 0.67, a current ratio of 1.04 and a debt-to-equity ratio of 1.05. The stock has a market cap of $49.75 billion, a price-to-earnings ratio of -24.82, a price-to-earnings-growth ratio of 2.03 and a beta of 0.57. The company’s 50-day moving average is $14.02 and its 200-day moving average is $12.51.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.06. Bayer Aktiengesellschaft had a negative net margin of 3.80% and a positive return on equity of 16.77%. The firm had revenue of $12.53 billion during the quarter, compared to analysts’ expectations of $12.31 billion. Bayer Aktiengesellschaft has set its FY 2026 guidance at 1.200-1.346 EPS. Equities research analysts expect that Bayer Aktiengesellschaft will post 1.28 earnings per share for the current fiscal year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft is a Germany-based life science company focused on health care and agriculture. Through its Pharmaceuticals, Consumer Health and Crop Science businesses, the company develops and markets products intended to improve human health, everyday self-care and agricultural productivity.

Bayer’s Pharmaceuticals business provides prescription medicines in areas such as cardiovascular disease, women’s health, oncology and specialty medicine. Its Consumer Health division offers nonprescription products in categories including pain relief, nutritional supplements, dermatology and allergy care, with brands such as Aspirin and Claritin.